Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
FDA Issues Final Rule on Antibacterial Soaps
FDA news release; 2016 Sep 2
The FDA has issued a final rule establishing that over-the-counter (OTC) consumer antiseptic wash products containing certain active ingredients can no longer be marketed. Under the final rule, companies will no longer be able to market antibacterial washes with these ingredients because manufacturers did not demonstrate that the ingredients are both safe for long-term daily use and more effective than plain soap and water in preventing illness and the spread of certain infections. Details of the final rule include:
• The final rule applies to consumer antiseptic wash products containing 1 or more of 19 active ingredients, including the most commonly used ingredients – triclosan and triclocarban.
• The rule does not affect antibacterial products used in health care settings.
• The FDA has deferred rulemaking for 1 year on 3 additional ingredients used in consumer wash products—benzalkonium chloride, benzethonium chloride, and chloroxylenol—to allow for the development and submission of new safety and effectiveness data for these ingredients.
Citation: The US Food and Drug Administration. FDA issues final rule of safety and effectiveness of antibacterial soaps. FDA Web site. September 2, 2016. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm517478.htm. Accessed September 4, 2016.
1. US Food and Drug Administration. Antibacterial soap? You can skip it—Use plain soap and water. Consumer updates. http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm378393.htm. Accessed September 9, 2016.